Theory-based Intervention for Promoting Responsible Gambling Among College Students
Launched by UNIVERSITY OF NEVADA, LAS VEGAS · Oct 13, 2024
Trial Information
Current as of July 23, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a program called RESPONSIBLEPLAY© to see if it can help college students at the University of Nevada, Las Vegas (UNLV) gamble more responsibly. The goal is to find out if this program can reduce harmful gambling behaviors and encourage safer gambling practices among students who are at risk for gambling problems. To participate, you must be at least 21 years old, a UNLV student, and have a gambling behavior score that shows you might be struggling with gambling.
If you qualify and choose to take part, you'll attend three in-person sessions over three weeks, where you'll learn about responsible gambling. You'll also fill out surveys before the sessions, right after, and eight weeks later to see how you're doing. This study is not yet recruiting participants, and it’s important to note that those currently receiving treatment for gambling issues or individuals who have cognitive impairments will not be eligible to join.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Must be at least 21 years old.
- • Must be a enrolled UNLV student.
- • Must engage in gambling activities.
- • Must have a score of 3 or higher on the Problem Gambling Severity Index (PGSI), indicating at-risk or problem gambling behavior.
- Exclusion Criteria:
- • Participants currently receiving treatment for gambling disorders.
- • Individuals with cognitive impairments that would affect their ability to provide consent or participate in the intervention.
- • Individuals who are not fluent in English (since the intervention materials and assessments will be conducted in English).
About University Of Nevada, Las Vegas
The University of Nevada, Las Vegas (UNLV) is a prominent research institution committed to advancing healthcare through innovative clinical trials. With a focus on multidisciplinary collaboration, UNLV engages in rigorous scientific inquiry to explore new treatments and interventions that address pressing health challenges. The university's dedicated faculty and state-of-the-art facilities foster an environment conducive to cutting-edge research, ensuring the highest standards of ethical practice and patient care. Through its clinical trials, UNLV aims to contribute to the body of medical knowledge while improving health outcomes for diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Las Vegas, Nevada, United States
Patients applied
Trial Officials
Manoj Sharma, PhD
Principal Investigator
University of Nevada, Las Vegas (UNLV)
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported